Katharina M Kubera Selected Research

Catatonia

9/2022	Characterizing the sensorimotor domain in schizophrenia spectrum disorders.
5/2022	Structural alterations of amygdala and hypothalamus contribute to catatonia.
12/2021	Intrinsic neural network dynamics in catatonia.
11/2021	Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon.
10/2020	Brainstem alterations contribute to catatonia in schizophrenia spectrum disorders.
1/2020	Going Back to Kahlbaum's Psychomotor (and GABAergic) Origins: Is Catatonia More Than Just a Motor and Dopaminergic Syndrome?
1/2020	Multimodal Magnetic Resonance Imaging Data Fusion Reveals Distinct Patterns of Abnormal Brain Structure and Function in Catatonia.
1/2020	Multiparametric mapping of white matter microstructure in catatonia.
10/2019	Cortical Contributions to Distinct Symptom Dimensions of Catatonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katharina M Kubera Research Topics

Disease

17	Schizophrenia (Dementia Praecox) 09/2022 - 01/2015
9	Catatonia 09/2022 - 10/2019
5	Parkinsonian Disorders (Parkinsonism) 09/2022 - 01/2020
3	Movement Disorders (Movement Disorder) 12/2021 - 01/2020
2	Psychomotor Agitation (Akathisia) 09/2022 - 01/2020
2	Psychotic Disorders (Schizoaffective Disorder) 01/2020 - 01/2019
2	Pathologic Processes 04/2016 - 02/2015
1	Tardive Dyskinesia 09/2022
1	Neuroleptic Malignant Syndrome 11/2021
1	Dyskinesias (Dyskinesia) 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2019

Drug/Important Bio-Agent (IBA)

14	Silver Sulfadiazine (SSD)FDA LinkGeneric 09/2022 - 01/2019
7	Antipsychotic Agents (Antipsychotics)IBA 11/2021 - 01/2015
1	GABA AgentsIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2019

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2019